A phase II study using vinorelbine and continuous 5-fluorouracil in patients with advanced head and neck cancer |
| |
Authors: | Larsen Susanne Serup-Hansen Eva Andersen Lisbeth J Lindeløv Birgit McCulloch Tine Adimi Parvin Bastholt Lars |
| |
Affiliation: | a Department of Oncology, Odense University Hospital, Odense, Denmarkb Department of Oncology, Aalborg, Denmarkc Department of Oncology, Vejle Hospital, Vejle, Denmark |
| |
Abstract: | Seventy patients with advanced head and neck cancer were treated with vinorelbine and continuous 5-FU administered in a central venous catheter. Over all response was 36% with 9% complete responses. The most common grade 3 and 4 toxicities were stomatitis (13), infection (5), pain related to vinorelbine infusion (4), skin toxicity (3). Thirty one patients had grade 3 or 4 leukopenia. Treatment was complicated by venous thrombosis in the central venous catheter in one case. A majority of patients experienced dose reduction of one or both drugs or treatment delays due to toxicity. Median time to progression was 4.7 months and overall median survival 6.6 months. We conclude that the regimen is feasible and tolerated with moderate toxicity. Response rates and time to progression are comparable to other studies with multi agent treatment. |
| |
Keywords: | |
本文献已被 InformaWorld PubMed 等数据库收录! |
|